Improving outcomes for people with skin tumours including melanoma
Improving outcomes for people with skin tumours including melanoma
Improving outcomes for people with skin tumours including melanoma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Dermal and subcutaneous <strong>tumours</strong><br />
Atypical fibroxanthoma (AFX) (superficial malignant fibrous<br />
histiocytoma, superficial sarcoma not otherwise specified).<br />
<strong>Improving</strong> Outcomes <strong>for</strong><br />
People <strong>with</strong> Skin Tumours<br />
<strong>including</strong> Melanoma<br />
Appendix 1<br />
Dermatofibrosarcoma protuberans (DFSP).<br />
Leiomyosarcoma.<br />
Angiosarcoma.<br />
Kaposi’s sarcoma.<br />
A1<br />
Haemangioendothelioma.<br />
Epithelioid sarcoma.<br />
Primary cutaneous rhabdomyosarcoma.<br />
Cutaneous malignant nerve sheath <strong>tumours</strong> (<strong>including</strong> cutaneous<br />
neurofibrosarcoma and malignant Schwannoma).<br />
Guidance on cancer services: <strong>skin</strong> <strong>tumours</strong> <strong>including</strong> <strong>melanoma</strong><br />
129